-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on ProMIS Neurosciences, Raises Price Target to $18

Benzinga·12/01/2025 15:59:56
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $4 to $18.